Premature ventricular contraction surgery: Difference between revisions
Homa Najafi (talk | contribs) |
Homa Najafi (talk | contribs) |
||
Line 51: | Line 51: | ||
| colspan="1" style="text-align:center; background:LightGreen"|[[ESC Guidelines Classification Scheme#Classification of Recommendations|Class I]] | | colspan="1" style="text-align:center; background:LightGreen"|[[ESC Guidelines Classification Scheme#Classification of Recommendations|Class I]] | ||
|- | |- | ||
| bgcolor="LightGreen"|<nowiki></nowiki>'''1.''' Patients with sustained VA and survivors of SCA should be evaluated for ischemic heart disease, and should be revascularized as | | bgcolor="LightGreen"|<nowiki></nowiki>'''1.''' Patients with sustained VA and survivors of SCA should be evaluated for ischemic heart disease, and should be revascularized as appropriate ''([[ACC AHA Guidelines Classification Scheme#Level of Evidence|Level of Evidence: B-NR]])''.<ref name="CookRizo-Patron2002">{{cite journal|last1=Cook|first1=James R.|last2=Rizo-Patron|first2=Carlos|last3=Curtis|first3=Anne B.|last4=Gillis|first4=Anne M.|last5=Bigger|first5=J.Thomas|last6=Kutalek|first6=Steven P.|last7=Coromilas|first7=James|last8=Hofer|first8=Bradley I.|last9=Powell|first9=Judy|last10=Hallstrom|first10=Alfred P.|title=Effect of surgical revascularization in patients with coronary artery disease and ventricular tachycardia or fibrillation in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Registry|journal=American Heart Journal|volume=143|issue=5|year=2002|pages=821–826|issn=00028703|doi=10.1067/mhj.2002.121732}}</ref><ref name="VelazquezLee2016">{{cite journal|last1=Velazquez|first1=Eric J.|last2=Lee|first2=Kerry L.|last3=Jones|first3=Robert H.|last4=Al-Khalidi|first4=Hussein R.|last5=Hill|first5=James A.|last6=Panza|first6=Julio A.|last7=Michler|first7=Robert E.|last8=Bonow|first8=Robert O.|last9=Doenst|first9=Torsten|last10=Petrie|first10=Mark C.|last11=Oh|first11=Jae K.|last12=She|first12=Lilin|last13=Moore|first13=Vanessa L.|last14=Desvigne-Nickens|first14=Patrice|last15=Sopko|first15=George|last16=Rouleau|first16=Jean L.|title=Coronary-Artery Bypass Surgery in Patients with Ischemic Cardiomyopathy|journal=New England Journal of Medicine|volume=374|issue=16|year=2016|pages=1511–1520|issn=0028-4793|doi=10.1056/NEJMoa1602001}}</ref> | ||
appropriate ''([[ACC AHA Guidelines Classification Scheme#Level of Evidence|Level of Evidence: B-NR]])''. | |||
'''2.''' In patients with anomalous origin of a coronary artery suspected to be the cause of SCA, repair or revascularization is recommended''([[ACC AHA Guidelines Classification Scheme#Level of Evidence|Level of Evidence: C-EO]])''.<nowiki/> | '''2.''' In patients with anomalous origin of a coronary artery suspected to be the cause of SCA, repair or revascularization is recommended''([[ACC AHA Guidelines Classification Scheme#Level of Evidence|Level of Evidence: C-EO]])''.<nowiki/> | ||
|- | |- |
Revision as of 21:40, 21 April 2020
Premature ventricular contraction Microchapters |
Differentiating Premature Ventricular Contraction from other Disorders |
---|
Diagnosis |
Treatment |
Case Studies |
Premature ventricular contraction surgery On the Web |
to Hospitals Treating Premature ventricular contraction surgery |
Risk calculators and risk factors for Premature ventricular contraction surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Homa Najafi, M.D.[2]
Overview
Surgical intervention is not recommended for the management of [disease name].
OR
Surgery is not the first-line treatment option for patients with [disease name]. Surgery is usually reserved for patients with either [indication 1], [indication 2], and [indication 3]
OR
The mainstay of treatment for [disease name] is medical therapy. Surgery is usually reserved for patients with either [indication 1], [indication 2], and/or [indication 3].
OR
The feasibility of surgery depends on the stage of [malignancy] at diagnosis.
OR
Surgery is the mainstay of treatment for [disease or malignancy].
Indications
- Surgical intervention is not recommended for the management of [disease name].
OR
- Surgery is not the first-line treatment option for patients with [disease name]. Surgery is usually reserved for patients with either:
- [Indication 1]
- [Indication 2]
- [Indication 3]
- The mainstay of treatment for [disease name] is medical therapy. Surgery is usually reserved for patients with either:
- [Indication 1]
- [Indication 2]
- [Indication 3]
Surgery
- The feasibility of surgery depends on the stage of [malignancy] at diagnosis.
OR
- Surgery is the mainstay of treatment for [disease or malignancy].
Contraindications
2017 AHA/ACC/HRS Guideline for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death (DO NOT EDIT)[1]
Recommendations for Surgery and Revascularization Procedures in Patients With Ischemic Heart Disease
Class I |
1. Patients with sustained VA and survivors of SCA should be evaluated for ischemic heart disease, and should be revascularized as appropriate (Level of Evidence: B-NR).[2][3]
|
References
- ↑ Al-Khatib, Sana M.; Stevenson, William G.; Ackerman, Michael J.; Bryant, William J.; Callans, David J.; Curtis, Anne B.; Deal, Barbara J.; Dickfeld, Timm; Field, Michael E.; Fonarow, Gregg C.; Gillis, Anne M.; Granger, Christopher B.; Hammill, Stephen C.; Hlatky, Mark A.; Joglar, José A.; Kay, G. Neal; Matlock, Daniel D.; Myerburg, Robert J.; Page, Richard L. (2018). "2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death". Circulation. 138 (13). doi:10.1161/CIR.0000000000000549. ISSN 0009-7322.
- ↑ Cook, James R.; Rizo-Patron, Carlos; Curtis, Anne B.; Gillis, Anne M.; Bigger, J.Thomas; Kutalek, Steven P.; Coromilas, James; Hofer, Bradley I.; Powell, Judy; Hallstrom, Alfred P. (2002). "Effect of surgical revascularization in patients with coronary artery disease and ventricular tachycardia or fibrillation in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Registry". American Heart Journal. 143 (5): 821–826. doi:10.1067/mhj.2002.121732. ISSN 0002-8703.
- ↑ Velazquez, Eric J.; Lee, Kerry L.; Jones, Robert H.; Al-Khalidi, Hussein R.; Hill, James A.; Panza, Julio A.; Michler, Robert E.; Bonow, Robert O.; Doenst, Torsten; Petrie, Mark C.; Oh, Jae K.; She, Lilin; Moore, Vanessa L.; Desvigne-Nickens, Patrice; Sopko, George; Rouleau, Jean L. (2016). "Coronary-Artery Bypass Surgery in Patients with Ischemic Cardiomyopathy". New England Journal of Medicine. 374 (16): 1511–1520. doi:10.1056/NEJMoa1602001. ISSN 0028-4793.